Interestingly, recent studies have also demonstrated that the therapeutic potential of GLP-1 action in the treatment of diseases such as T2D and dementia can likely be enhanced by co-activation of other receptors involved in maintaining metabolic homeostasis. Here, GCG is linked to type 2 diabetes mellitus.